Company profile for Predicine

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Predicine stands as a global molecular insights company dedicated to advancing precision medicine in the field of oncology. The company has achieved a breakthrough in liquid biopsy technology, utilizing cell-free DNA and cell-free RNA for minimally invasive molecular diagnosis. This innovative approach facilitates treatment selection, therapy monitoring, and the detection of minimal residual disease and early-stage cancer. Pre...
Predicine stands as a global molecular insights company dedicated to advancing precision medicine in the field of oncology. The company has achieved a breakthrough in liquid biopsy technology, utilizing cell-free DNA and cell-free RNA for minimally invasive molecular diagnosis. This innovative approach facilitates treatment selection, therapy monitoring, and the detection of minimal residual disease and early-stage cancer. Predicine has successfully launched a comprehensive portfolio of diagnostic assays for oncology, spanning blood, urine, and tissue-based testing.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
Hayward, CA 94545
Telephone
Telephone
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/09/02/3142717/0/en/Predicine-Submits-First-Module-of-PMA-Application-to-FDA-for-PredicineCARE-as-a-Companion-Diagnostic-Assay-in-Bladder-Cancer.html

GLOBENEWSWIRE
02 Sep 2025

https://www.globenewswire.com/news-release/2024/11/06/2975978/0/en/UPDATE-PredicineCARE-Liquid-Biopsy-Assay-Featured-in-NEJM-for-patient-enrollment-in-Phase-III-Breast-Cancer-Trial.html

GLOBENEWSWIRE
06 Nov 2024

https://www.globenewswire.com/news-release/2024/11/04/2974321/0/en/PredicineCARE-Liquid-Biopsy-Assay-Featured-in-NEJM-as-Pivotal-Tool-in-Roche-s-Phase-III-Itovebi-Breast-Cancer-Trial.html

GLOBENEWSWIRE
04 Nov 2024

https://www.globenewswire.com/news-release/2024/05/22/2886158/0/en/Predicine-to-Present-9-Liquid-Biopsy-Studies-at-ASCO-2024.html

GLOBENEWSWIRE
22 May 2024

https://www.globenewswire.com/news-release/2024/04/12/2861963/0/en/UPDATE-Predicine-Introduces-PredicineCARE-NGS-Kit-for-Tumor-Profiling.html

GLOBENEWSWIRE
11 Apr 2024

https://www.globenewswire.com/news-release/2024/04/05/2858738/0/en/Predicine-Announces-Collaboration-with-Apollomics-to-Develop-PredicineCARE-as-a-Companion-Diagnostic-Assay-in-Lung-Cancer.html

GLOBENEWSWIRE
05 Apr 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty